An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer

BACKGROUND: Metastatic breast cancer (MBC) is incurable, with a 5-year survival rate of 28%. In the USA, more than 42,000 patients die from MBC every year. The most common type of breast cancer is estrogen receptor-positive (ER+), and more patients die from ER+ breast cancer than from any other subt...

Descripción completa

Detalles Bibliográficos
Autores principales: Scherer, Sandra D., Riggio, Alessandra I., Haroun, Fadi, DeRose, Yoko S., Ekiz, H. Atakan, Fujita, Maihi, Toner, Jennifer, Zhao, Ling, Li, Zheqi, Oesterreich, Steffi, Samatar, Ahmed A., Welm, Alana L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556932/
https://www.ncbi.nlm.nih.gov/pubmed/34717714
http://dx.doi.org/10.1186/s13058-021-01476-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556932/
https://www.ncbi.nlm.nih.gov/pubmed/34717714
http://dx.doi.org/10.1186/s13058-021-01476-x

Ejemplares similares